Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

A virtual reality intervention administered during chemotherapy infusion yielded statistically significant reductions in stress, pain and heart rate among patients, according to a study published ...

When cancer cells are in, or could get to, the fluid around your brain, intrathecal chemotherapy is the way to deliver cancer-fighting drugs right to the area. Find out how it works and what you ...

The first patient has been dosed in a phase 2b trial evaluating the first-in-class agent Halneuron for those with neuropathic pain following chemotherapy.

More than 40% of patients treated with chemotherapy develop persistent peripheral nerve pain, findings showed. Prevalence of chronic chemotherapy-induced peripheral neuropathy (CIPN) varied by ...

Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need for personalized treatment strategies.

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests. These patients might ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Stabbing, burning or tingling pain can be chronic in cancer patients who undergo chemotherapy. A new study found that 4 in 10 patients get persistent and severe nerve pain from the cancer treatment.